Galmed Pharmaceuticals (EOCN) Net Cash Flow (2013 - 2026)
Galmed Pharmaceuticals' Net Cash Flow came in at $116,000 for Q2 2026, down 41.4% from $198,000 a year earlier.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Net Cash Flow (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Galmed Pharmaceuticals reported Net Cash Flow of $4.81 million, up 289.5% year-over-year; for FY2025, it came in at $7.39 million, down 10.3% from FY2024.
- Going back by year, Net Cash Flow was $8.24 million in FY2024 (+871.1%), $848,000 in FY2023, -$868,000 in FY2022 and -$4.06 million in FY2021.
- The five-year range for quarterly Net Cash Flow is -$6.96 million (Q2 2022) to $8.72 million (Q4 2025).
- Year-over-year, Net Cash Flow increased in 1 of the last four quarters, with growth averaging 111.8%.
- Business Quant data shows EOCN's Net Cash Flow at -$2.38 million (Q1 2026), $8.72 million (Q4 2025) and -$1.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - | 116,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116,000.00 |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | 8.72 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | -450,000.00 |
| Jun 30, 2024 | 375,000.00 |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | -5.71 Mn |
| Jun 30, 2023 | -662,000.00 |
| Mar 31, 2023 | -214,000.00 |
| Dec 31, 2022 | -2.05 Mn |
| Sep 30, 2022 | 2.01 Mn |
| Jun 30, 2022 | -6.96 Mn |
| Mar 31, 2022 | 6.23 Mn |
| Dec 31, 2021 | -605,000.00 |
| Sep 30, 2021 | -4.43 Mn |
API Access
Galmed Pharmaceuticals Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();